Skip to main content

Clinical Trials in Regenerative Medicine and Their Challenges

Edited by:

Akihiro Umezawa, PhD, National Research Institute for Child Health and Development, Japan

Submission Status: Open   |   Submission Deadline: 30 June 2025


Stem Cell Research & Therapy is calling for submissions to our Collection on Clinical Trials in Regenerative Medicine and Their Challenges. This Collection delves into the pivotal role of clinical trials in advancing regenerative medicine, emphasizing the unique challenges faced in this transformative field.

About the Collection

Regenerative medicine, with its potential to repair, replace, and regenerate damaged tissues and organs, holds immense promise for treating a wide range of diseases and injuries. However, translating laboratory discoveries into clinical applications involves navigating complex regulatory landscapes, ethical considerations, and the inherent unpredictability of biological systems.

This Collection aims to highlight cutting-edge research, case studies, and reviews that address these challenges, providing insights into the strategies and innovations that are shaping the future of regenerative medicine.

  1. This study assesses the safety and efficacy of hepatocyte-like cell (HLC) infusion therapy derived from human embryonic stem cells as bridging therapy for neonatal-onset urea cycle disorders (UCD). The researc...

    Authors: Akihiro Umezawa, Akinari Fukuda, Reiko Horikawa, Hajime Uchida, Shin Enosawa, Yoshie Oishi, Naoko Nakamura, Kengo Sasaki, Yusuke Yanagi, Seiichi Shimizu, Toshimasa Nakao, Tasuku Kodama, Seisuke Sakamoto, Itaru Hayakawa, Saeko Akiyama, Noriaki Saku…
    Citation: Stem Cell Research & Therapy 2025 16:120
    Content type: Research Published on:

Submission Guidelines

Back to top

This Collection welcomes submissions of original research and review articles. Should you wish to submit a different article type, please read our submission guidelines to confirm that type is accepted by the journal. 

Articles for this Collection should be submitted via Editorial Manager. Please select the appropriate Collection title “Clinical Trials in Regenerative Medicine and Their Challenges" from the dropdown menu.

Articles will undergo the journal’s standard peer-review process and are subject to all the journal’s standard policies. Articles will be added to the Collection as they are published.

The Editors have no competing interests with the submissions which they handle through the peer-review process. The peer-review of any submissions for which the Editors have competing interests is handled by another Editorial Board Member who has no competing interests.